Tag: AI

Viz.ai partners with Cercare to support neurovascular clinical decision-making

Viz.ai has announced a partnership with Cercare Medical that will incorporate the latter’s Cercare Perfusion—a fully-automated, simple-to-use, patient-specific perfusion software—into the Viz artificial intelligence...

Aidoc secures new FDA clearances for neurovascular and cardiovascular detection tools

Aidoc has announced it has increased its total number of US Food and Drug Administration (FDA) clearances to 11 with the addition of two...

Viz.ai and Vastrax join forces to accelerate neurovascular clinical trial enrolment

Viz.ai has announced a strategic partnership with full-service, vascular clinical research organisation (CRO) Vastrax. Together, the two companies intend to accelerate clinical trial enrolment for...
Rapid ich

Rapid ICH receives new US FDA clearance with “highest sensitivity and...

RapidAI has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the latest release of Rapid ICH—a technology that it describes as...

Philips to highlight latest advances in stroke care at 2022 World...

Royal Philips today announced it will showcase the company’s latest advances to support the treatment of stroke patients at the 14th annual World Stroke...

RAPID Aneurysm programme shows positive early performance in retrospective study

RAPID Aneurysm, a semi-automated artificial intelligence (AI) software programme (RapidAI), is highly accurate in detecting cerebral aneurysms on computed tomography angiography (CTA) imaging, according...

How AI, automation, robotics and other innovations in ultrasound are improving...

Robert Hamilton (Los Angeles, USA) outlines several key milestones in the history of stroke care, and discusses how recent technological advances in this space...

Brainomix awarded tender to roll out AI imaging software across all...

Brainomix has announced that it has been awarded the national tender in Hungary to deploy its artificial intelligence (AI) stroke imaging software across all stroke centres...

SNIS 2022: Research shows AI-based stroke diagnostics can expand access to...

A new study presented at the Society of NeuroInterventional Surgery’s (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) shows that artificial intelligence (AI) technology...

Viz.ai receives US FDA 510(k) clearance for Viz SDH, announces Hyperfine...

Viz.ai today announced it has received US Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural (SDH). The Viz SDH algorithm uses artificial...
Rapid ich

RapidAI receives US FDA clearance for Rapid Hyperdensity

RapidAI has announced receipt of US Food and Drug Administration (FDA) clearance for Rapid Hyperdensity—the newest addition to the RapidAI platform. According to the company,...

Robotics, AI and other innovations in stroke and aneurysm care on...

Specialists from around the world will gather at the Society of NeuroInterventional Surgery's (SNIS) 19th annual meeting (25–29 July, Toronto, Canada) next week to discuss...

AI-powered device delivers “amazing physiologic information” to guide thrombectomy treatments

The Clotild smart guidewire system (Sensome), which uses artificial intelligence (AI) to provide real-time insights on clot composition, is showing early promise in the...

Artificial intelligence tutoring outperforms expert instructors in neurosurgical training

Against the backdrop of remote learning technologies becoming increasingly important within medical training during the COVID-19 pandemic, a new study has found that—in a...

Avicenna.AI signs distribution agreement with Sectra for neurovascular AI solutions

Avicenna.AI has announced a signed distribution agreement with Sectra—an international medical imaging information technology (IT) and cybersecurity company. The agreement will see Avicenna’s AI...

Zeta Surgical secures US$5.2 million to enhance AI-driven neurosurgical technologies

Zeta Surgical has announced the close of US$5.2 million in seed financing—and will use these funds to finalise development of its neurosurgical navigation platform, Zeta,...
ai cerebral aneurysm

Pushing the boundaries of aneurysm detection, monitoring and care with AI

Alejandro Spiotta (Medical University of South Carolina, Charleston, USA) outlines what he believes could be the next frontier in cerebral aneurysm care—artificial intelligence (AI)—and...

AI, cost reductions and more represent bright future for neuromodulation industry

On technological and commercial fronts alike, the neuromodulation space is one of the more rapidly evolving subsectors within the medical industry—and has undergone a...

Viz.ai receives FDA 510(k) clearance for cerebral aneurysm detection algorithm

Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for Viz ANEURYSM—a new algorithm that uses artificial intelligence (AI) to detect suspected...

RapidAI announces Karim Karti as new CEO

RapidAI has announced Karim Karti, former president and CEO of GE Healthcare Imaging, as the company’s chief executive officer (CEO). “Karim’s tremendous global experience in...
artificial intelligence stroke care

Time savings, cost reductions and improved patient outcomes all key benefits...

Artificial intelligence (AI) and the role it can play in improving acute ischaemic stroke care protocols took centre stage at the Barts Research and...
StrokeViewer nicolab

AI holds the key to timely interventions in a field where...

This advertorial is sponsored by Nicolab.  In 2021, the Royal Infirmary of Edinburgh and networking hospitals are implementing StrokeViewer (Nicolab)—which is an artificial intelligence (AI)...

New study finds e-Stroke software shortens treatment times and improves functional...

A new study presented at the 13th World Stroke Congress (WSC 2021; 28–29 October, virtual) found that the implementation of Brainomix's e-Stroke software resulted in...

ESOC 2021: AI can calculate personalised risk of having another stroke

Artificial intelligence (AI) can be used to give stroke patients a personalised and more accurate assessment of their risk of suffering a recurrence, according...
qure.ai

Qure.ai lands second FDA clearance for AI-based brain scan technology

Qure.ai has announced US Food and Drug Administration (FDA) 510(k) clearance for its brain computed tomography (CT) quantification product qER-Quant. Clinicians in the USA...

Viz.ai receives CE mark to bring AI-powered stroke care software to...

Viz.ai has been awarded a CE mark for its artificial intelligence (AI)-powered stroke care software, affirming its conformity with European health, safety and environmental...
sensome clot out

Sensome’s AI-powered stroke guidewire granted FDA Breakthrough Device designation

Sensome has announced its Clotild Smart Guidewire System—designed to improve the treatment of ischaemic stroke patients—has been granted a Breakthrough Device designation by the...
viz.ai medtronic

Medtronic, Viz.ai partner to bring “lifesaving” AI platform for stroke to...

Medtronic and Viz.ai have announced they are extending their successful US partnership to distribute Viz.ai’s "lifesaving" artificial intelligence (AI) software platform for stroke to...

BrainQ trial results show a potential reduction in disability after stroke

BrainQ, an Israeli start-up with an artificial intelligence- (AI) powered therapeutic platform, has announced the results from a randomised controlled trial (RCT), showing 77%...

Stryker partners with Brainomix for AI stroke software

Stryker has announced a new partnership with Brainomix that provides an option for European customers to purchase Brainomix’s e-Stroke software.  According to a press release...
rapidAI Rapid LVO FDA approval

RapidAI announces software approval for Medicare New Technology Add-on Payment

RapidAI states Rapid LVO is among the first software products to qualify for the New Technology Add-on Payment (NTAP). NTAP is part of the CMS...
rapidAI Rapid LVO FDA approval

RapidAI receives FDA clearance of Rapid LVO for identification of suspected...

RapidAI has announced that Rapid LVO has received US Food and Drug Administration (FDA) clearance for detecting suspected large vessel occlusions (LVOs). Rapid LVO helps...
rapidAI Rapid LVO FDA approval

Rapid ASPECTS receives CADx clearance from the FDA

RapidAI has announced that Rapid ASPECTS has received US Food and Drug Administration (FDA) clearance as the first neuroimaging analysis device in the CADx (computer-assisted...

Study shows novel AI technology is better predictor of stroke than...

Boston-based medical technology company Elucid Bio, maker of the Food and Drug Administration (FDA)-cleared and CE-marked vascuCAP software, announced Wednesday, July 1, that its...
artificial intelligence

Viz.ai adds new capabilities to its AI stroke platform

Viz.ai has launched the next generation of its synchronized care platform for stroke. Viz.ai incorporates cutting edge artificial intelligence with HIPAA-compliant communication to allow...
aidoc AI stroke treatment

US FDA clears Aidoc’s complete AI stroke package

Aidoc has announced that the US Food and Drug Administration (FDA) has cleared its AI solution for flagging large vessel occlusion (LVO) in head...

Philips extends AI portfolio with launch of IntelliSpace AI Workflow Suite...

Philips announces the launch of IntelliSpace AI Workflow Suite to enable healthcare providers to seamlessly integrate AI applications into the imaging workflow. Part of...
artificial intelligence

Viz.ai launches a range of new AI features

Viz.ai has announced a number of new features at the Society of Vascular and Interventional Neurology (SVIN) annual meeting in Atlanta, USA (20–23 November,...
Nick Murray AI software

Although “unperfected”, AI has the potential to accelerate and synchronise stroke...

A recently published systematic review reveals that artificial intelligence (AI) is rapidly being used by major medical centres to identify large vessel occlusions (LVO)...
brainomix

Brainomix AI software improves stroke treatment rates at Budapest University Hospital

On the 8th of November 2019, during a symposium at the annual meeting of the Hungarian Neuroradiology Society (MNRT) in Mátraháza, Hungary, Bence Gunda...
icometrix guerbet

Guerbet signs agreement with icometrix for the distribution of icobrain, an...

Guerbet announces that it has signed an exclusive agreement with icometrix for the distribution in France, Italy and Brazil of icobrain, their Saas (Software...
AI aneurysm

New AI tool for detecting cerebral aneurysms enhances clinicians’ accuracy

Through developing a deep learning model to automatically detect clinically significant intracranial aneurysms on computed tomography (CT) angiography, clinicians’ sensitivity, accuracy, and interrater reliability...